For example, we recently reported that inhibiting glycolysis in PDAC tumor-conditioned macrophages in vitro, using a competitive HK2 inhibitor (2-deoxyglucose), reversed their pro-metastatic phenotype [9]. This evidence concerns the gene HK2 and neoplasm.